OKAIF (EvokAI Creative Labs) Cash Flow for Dividends: $0.00 Mil (TTM As of Sep. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OKAIF EvokAI Creative Labs Inc OKAIF
15 GF Score
Price $0.12
View Full Analysis

What is EvokAI Creative Labs Cash Flow for Dividends?

EvokAI Creative Labs OKAIF -30.15% 15 Cash Flow for Dividends is $0.00 Mil as of Sep. 2024. GuruFocus rates OKAIF with a GF Score™ of 15/100.

EvokAI Creative Labs's cash flow for dividends for the three months ended in Sep. 2024 was $0.00 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Sep. 2024 was $0.00 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

EvokAI Creative Labs Cash Flow for Dividends Related Terms

EvokAI Creative Labs Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for EvokAI Creative Labs's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EvokAI Creative Labs Cash Flow for Dividends Chart

EvokAI Creative Labs Annual Data
Trend Dec21 Dec22 Dec23
Cash Flow for Dividends
0.00 0.00 0.00

EvokAI Creative Labs Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
OKAIF
15GF Score
EvokAI Creative Labs Inc OKAIF
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

EvokAI Creative Labs Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of $0.00 Mil mean?
EvokAI Creative Labs (OKAIF) has a Cash Flow for Dividends of $0.00 Mil as of Sep. 2024. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for EvokAI Creative Labs and its competitors.
Is EvokAI Creative Labs' Cash Flow for Dividends too high?
EvokAI Creative Labs' current Cash Flow for Dividends is $0.00 Mil. Overall, EvokAI Creative Labs has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does EvokAI Creative Labs' Cash Flow for Dividends compare to VEEV and GEHC?
EvokAI Creative Labs' Cash Flow for Dividends of $0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Healthcare Providers & Services company?
A good Cash Flow for Dividends depends on the Healthcare Providers & Services industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for EvokAI Creative Labs and its competitors. EvokAI Creative Labs's current Cash Flow for Dividends is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EvokAI Creative Labs stock overvalued right now?
EvokAI Creative Labs (OKAIF) has a current Cash Flow for Dividends of $0.00 Mil. The current Cash Flow for Dividends is $0.00 Mil. EvokAI Creative Labs' overall GF Score™ is 15/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For EvokAI Creative Labs (OKAIF), the current Cash Flow for Dividends is $0.00 Mil as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

EvokAI Creative Labs Business Description

Address 609 Granville Street, Suite 1600, PO Box 10068, Pacific Centre, Vancouver, BC, CAN, V7Y 1C3
EvokAI Creative Labs Inc is a medtech artificial-intelligence-powered company. It deploys machine learning models to search medical data and uncover insights to help improve health outcomes, patient experiences, drug development, preclinical and clinical decisions, and provide more accurate diagnoses. EvokAI tailors its AI algorithms across the whole healthcare system, from hospitals, private clinics, research institutions, pharmaceutical companies, and contract research organizations to medical professionals, patients, and healthy individuals aiming at preventing and early detecting any kind of disease and beyond, protecting the aging genome.
15GF Score

Get the complete analysis for OKAIF

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.12
Price